Back to results
US 10,945,988 B2Granted
Treatment of circadian rhythm disorders
AssigneeVanda Pharmaceuticals Inc.
InventorsMarlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
Claims13
A method of treating a disorder associated with a desynchronous cortisol circadian rhythm in a patient having a desynchronous cortisol circadian rhythm, said method comprising internally administering to the patient an effective amount of tasimelteon.
Dependencies are inferred from the claim text.